Evidence map›Paper›PMID 41598006›Full record

ArticleMaterials (Basel, Switzerland)2026

Electronic Structure of Graphene-Doped PEDOT:PSS and Its Influence on Energy-Level Alignment with p-Type Organic Semiconductor ZnPc.

Woojin Shin, Hyunbok Lee

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Woojin ShinDepartment of Semiconductor Physics, Institute of Forest Science, Kangwon National University, 1 Gangwondaehak-gil, Chuncheon-si 24341, Gangwon-do, Republic of Korea.ORCID 0009-0007-9116-2687
Hyunbok LeeDepartment of Semiconductor Physics, Institute of Forest Science, Kangwon National University, 1 Gangwondaehak-gil, Chuncheon-si 24341, Gangwon-do, Republic of Korea.ORCID 0000-0002-3046-1524

Funding

National Research Foundation of Korea RS-2018-NR031068National Research Foundation of Korea RS-2021-NR058424National Research Foundation of Korea RS-2025-25405766
6 · The paper itself

Abstract

Poly (3,4-ethylenedioxythiophene polystyrene sulfonate) (PEDOT:PSS) is a solution-processable hole transport layer known for its high work function and excellent hole mobility. The incorporation of graphene serves as an effective strategy to augment the hole-transport properties of PEDOT:PSS. In this study, the electronic structure of graphene-doped PEDOT:PSS (G-PEDOT:PSS) was investigated using X-ray photoelectron spectroscopy (XPS) and ultraviolet photoelectron spectroscopy (UPS). It was found that the work function of PEDOT:PSS increases with graphene doping concentration, rising from 4.86 eV for undoped PEDOT:PSS to 5.03 eV for PEDOT:PSS incorporating 10 wt% graphene. The impact of this modification on the energy-level alignment with zinc phthalocyanine (ZnPc), which is a prototypical p-type organic semiconductor, was examined through in situ XPS and UPS analyses. Despite the increased work function, the hole injection barriers for both PEDOT:PSS and G-PEDOT:PSS to ZnPc were determined to be identical at 0.26 eV. This lack of change in the barrier is explicitly attributed to Fermi-level pinning, where the integer charge transfer level of ZnPc is pinned to the Fermi level of the substrate, preventing a further reduction in the energy offset. That said, for other p-type organic semiconductors with higher ionization energies, the use of G-PEDOT:PSS could potentially enable more efficient hole injection.

Indexed as

energy-level alignmentgraphenePEDOT:PSSUPSXPS

Identifiers

PMID41598006
PMCPMC12842689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.